Cardiff Oncology, Inc.
CRDFNASDAQHealthcare● Active
$1.50
+$0.00(+0.00%)
Market Cap$102554844
P/E Ratio—
52W High$4.56
52W Low$1.35
Cardiff Oncology, Inc.（CRDF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CRDF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.59M | $0.68M | $0.49M | $0.39M | $0.36M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.59M | $0.68M | $0.49M | $0.39M | $0.36M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $35.33M | $36.85M | $32.86M | $27.11M | $17.38M |
| G&A Expenses | $14.22M | $12.48M | $13.04M | $13.18M | $11.84M |
| Total Operating Expenses | $49.55M | $49.33M | $45.90M | $40.29M | $29.21M |
| Operating Income | ($48.96M) | ($48.65M) | ($45.41M) | ($39.90M) | ($28.86M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $3.10M | $3.26M | $4.07M | $1.58M | $0.26M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($45.85M) | ($45.43M) | ($41.44M) | ($38.70M) | ($28.29M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($45.85M) | ($45.43M) | ($41.44M) | ($38.70M) | ($28.29M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 |
| Wtd Avg Shares | 66.84M | 47.65M | 44.68M | 43.60M | 39.03M |
| EBITDA | ($48.06M) | ($48.25M) | ($45.01M) | ($39.67M) | ($28.40M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Cardiff Oncology, Inc.
关于Cardiff Oncology, Inc.（CRDF）损益表
Cardiff Oncology, Inc.（CRDF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CRDF实现营收$0.00B，毛利润$0.00B（毛利率100.00%），净利润($0.05B)（净利率-7732.04%）。
常见问题
CRDF · 4 问Cardiff Oncology, Inc.（CRDF）2025财年营收为$0.00B，同比down13.2%。
CRDF revenueCRDF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09